Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of neuro-immunological factors in the pathophysiology of mood disorders
Anindya Bhattacharya, Noel Derecki, Timothy W. Lovenberg, et al.
Psychopharmacology (2016) Vol. 233, Iss. 9, pp. 1623-1636
Closed Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Treatment-resistant depression and peripheral C-reactive protein
Samuel R. Chamberlain, Jonathan Cavanagh, Peter de Boer, et al.
The British Journal of Psychiatry (2018) Vol. 214, Iss. 1, pp. 11-19
Open Access | Times Cited: 323
The role of neuroimmune signaling in alcoholism
Fulton T. Crews, Colleen J. Lawrimore, T. Jordan Walter, et al.
Neuropharmacology (2017) Vol. 122, pp. 56-73
Open Access | Times Cited: 274
Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis
Samuel P. Leighton, Louis Nerurkar, Rajeev Krishnadas, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 1, pp. 48-58
Open Access | Times Cited: 248
Neuroinflammation as a risk factor for attention deficit hyperactivity disorder
Geoffrey A. Dunn, Joel T. Nigg, Elinor L. Sullivan
Pharmacology Biochemistry and Behavior (2019) Vol. 182, pp. 22-34
Open Access | Times Cited: 218
Biological hypotheses and biomarkers of bipolar disorder
Ekaterina Sigitova, Zdeněk Fišar, Jana Hroudová, et al.
Psychiatry and Clinical Neurosciences (2016) Vol. 71, Iss. 2, pp. 77-103
Open Access | Times Cited: 212
Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 203
Pathways Connecting Late-Life Depression and Dementia
Christoph Linnemann, Undine E. Lang
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 165
Attention-Deficit/Hyperactivity Disorder And Inflammation: What Does Current Knowledge Tell Us? A Systematic Review
Deepa Anand, Gabriela Delevati Colpo, Gregory Zeni, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 166
The role of microglial P2X7: modulation of cell death and cytokine release
Yingbo He, Natalie Taylor, Lawrence Fourgeaud, et al.
Journal of Neuroinflammation (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 153
Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target
Filippo Caraci, Simona Federica Spampinato, Maria Grazia Morgese, et al.
Pharmacological Research (2018) Vol. 130, pp. 374-384
Open Access | Times Cited: 144
The ketone body metabolite β‐hydroxybutyrate induces an antidepression‐associated ramification of microglia via HDACs inhibition‐triggered Akt‐small RhoGTPase activation
Chao Huang, Peng Wang, Xing Xu, et al.
Glia (2017) Vol. 66, Iss. 2, pp. 256-278
Closed Access | Times Cited: 125
The Effectiveness of Aromatherapy for Depressive Symptoms: A Systematic Review
Dalinda Isabel Sánchez-Vidaña, Shirley P.C. Ngai, Aaron W. J. He, et al.
Evidence-based Complementary and Alternative Medicine (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 123
Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: A randomized controlled trial
Faith Dickerson, Maria Adamos, Emily Katsafanas, et al.
Bipolar Disorders (2018) Vol. 20, Iss. 7, pp. 614-621
Open Access | Times Cited: 119
Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR
W Nowak, Leandro Nicolás Grendas, Liliana M. Sanmarco, et al.
EBioMedicine (2019) Vol. 50, pp. 290-305
Open Access | Times Cited: 116
The role of adenosine receptors in mood and anxiety disorders
Dietrich van Calker, Knut Biber, Katharina Domschke, et al.
Journal of Neurochemistry (2019) Vol. 151, Iss. 1, pp. 11-27
Open Access | Times Cited: 110
Modeling consequences of prolonged strong unpredictable stress in zebrafish: Complex effects on behavior and physiology
Cai Song, Bai-Ping Liu, Yongping Zhang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 81, pp. 384-394
Closed Access | Times Cited: 104
Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders
Anindya Bhattacharya
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 99
Endogenous Neurosteroid (3α,5α)3-Hydroxypregnan-20-one Inhibits Toll-like-4 Receptor Activation and Pro-inflammatory Signaling in Macrophages and Brain
Irina Balan, Matthew C. Beattie, Todd K. O’Buckley, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 97
Topography of microglial activation in sensory‐ and affect‐related brain regions in chronic pain
Anna M.W. Taylor, Sadaf Mehrabani, Steve Liu, et al.
Journal of Neuroscience Research (2016) Vol. 95, Iss. 6, pp. 1330-1335
Open Access | Times Cited: 91
Inflammation in cancer and depression: a starring role for the kynurenine pathway
Luca Sforzini, Maria Antonietta Nettis, Valeria Mondelli, et al.
Psychopharmacology (2019)
Open Access | Times Cited: 87
Innate Immune Signaling and Alcohol Use Disorders
Leon G. Coleman, Fulton T. Crews
Handbook of experimental pharmacology (2018), pp. 369-396
Open Access | Times Cited: 84
Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorder
Claire Green, Xueyi Shen, Anna J. Stevenson, et al.
Brain Behavior and Immunity (2020) Vol. 92, pp. 39-48
Open Access | Times Cited: 77
Brexanolone therapeutics in post-partum depression involves inhibition of systemic inflammatory pathways
Irina Balan, Riah Patterson, Giorgia Boero, et al.
EBioMedicine (2023) Vol. 89, pp. 104473-104473
Open Access | Times Cited: 41
Immune mechanisms of depression in rheumatoid arthritis
James B. Brock, Neil Basu, Johannes C. M. Schlachetzki, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 12, pp. 790-804
Closed Access | Times Cited: 33
Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions
Riah Patterson, Irina Balan, A. Leslie Morrow, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 67-72
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top